πŸ‡ΊπŸ‡Έ FDA
Patent

US 8003622

Peptide biosynthesis and pain therapy

granted A61KA61K48/005A61P

Quick answer

US patent 8003622 (Peptide biosynthesis and pain therapy) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K48/005, A61P, A61P25/00, A61P25/04